Pfizer Inc.

NYSE:PFE   3:59:59 PM EDT
52.47
+1.82 (+3.59%)
5:09:00 PM EDT: $52.42 -0.05 (-0.10%)
Other Pre-Announcement

Pfizer Reports First-Quarter 2022 Results

Published: 05/03/2022 12:44 GMT
Pfizer Inc. (PFE) - Pfizer Reports First-quarter 2022 Results.
Q1 Adjusted Earnings per Share $1.62.
Q1 Earnings per Share $1.37.
First-quarter 2022 Revenues of $25.7 Billion, Reflecting 82% Operational Growth.
Reaffirms Full-year 2022 Financial Guidance for Revenues of $98.0 to $102.0 Billion.
On Track to Fulfill Our Commitment to Deliver at Least 2 Billion Doses to Low- and Middle-income Countries in 2021 and 2022.
Reaffirms 2022 Revenue Guidance for Comirnaty of About $32 Billion, Despite a About $1 Billion Unfavorable Impact From Foreign Exchange.
Reaffirms 2022 Revenue Guidance for Paxlovid of Approximately $22 Billion, Despite a About $0.5 Billion Unfavorable Impact From Foreign Exchange.
Have Chosen to Continue to Supply People of Russia With Medications They Need.
Full-year 2022 Financial Guidance for Adjusted Diluted EPS Revised to a Range of $6.25 to $6.45.
Pfizer - 2022 Adjusted Diluted EPS Guidance Revised to Reflect $0.11 Negative Impact for Accounting Policy Change to Include Acquired In-process Research and Development Expenses in Adjusted Results.
Current 2022 Financial Guidance Does Not Anticipate Any Additional Share Repurchases in 2022.
Pfizer - Q1 Operational Growth Primarily Driven by Comirnaty Globally, Which Grew $10.2 Billion Operationally to $13.2 Billion in Direct Sales, Alliance Revenue.
Qtrly Prevnar Family Worldwide Revenue $ 1,565 Million Versus $ 1,284 Million.
Q1 Earnings per Share View $1.47, Revenue View $23.86 Billion -- Refinitiv Ibes Data (analyst estimates).